Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia
Authors:
- L E TuneLTL E Tune
- I CreeseICI Creese
- J R DepauloJDJ R Depaulo
- P R SlavneyPSP R Slavney
- J T CoyleJCJ T Coyle
- S H SnyderSSS H Snyder
- 1 February 1980
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 137 (2) , 187-190
Abstract
The authors measured serum neuroleptic levels by radioreceptor assay in 30 schizophrenic patients receiving haloperidol, fluphenazine, chlorpromazine, molindone, thiothixene, or trifluoperazine. Neuroleptic levels were significantly correlated with clinical state, monitored by an abbreviated version of the Present State Examination (the mini-PSE). Poor therapeutic responses were associated with serum levels under 50 ng/ml chlorpromazine equivalents. There was no correlation between neuroleptic dosage and mini-PSE score or between neuroleptic dose and serum neuroleptic levels.Keywords
This publication has 15 references indexed in Scilit:
- Antischizophrenic drugs: Differential plasma protein binding and therapeutic activityLife Sciences, 1979
- 3H-haloperidol binding to dopamine receptors in rat corpus striatum: Influence of chlorpromazine metabolites and derivativesEuropean Journal of Pharmacology, 1978
- Biochemical Actions of Neuroleptic Drugs: Focus on the Dopamine Receptor1978
- A simple and sensitive radioreceptor assay for antischizophrenic drugs in bloodNature, 1977
- Clinical significance of plasma chlorpromazine levels I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatmentPsychological Medicine, 1976
- Comparative Doses and Costs of Antipsychotic MedicationArchives of General Psychiatry, 1976
- Effects of chlorpromazine and three metabolites on behavioral responses in ratsPsychopharmacology, 1974
- Dose equivalence of the anti-psychotic drugsJournal of Psychiatric Research, 1974
- Effects of mode of management on plasma chlorpromazine in psychiatric patientsClinical Pharmacology & Therapeutics, 1973
- Physiologic and clinical effects of chlorpromazine and their relationship to plasma levelClinical Pharmacology & Therapeutics, 1972